Accelerating Peptide Development: Strategies to optimize the formulation and manufacture of peptide therapeuticsRegister here
When you are looking for a partner who is dedicated to Phase I trials and early development, rely on Quotient Sciences. We accelerate your molecule from first-in-human to proof-of-concept, helping you make critical decisions earlier. Whatever clinical pharmacology study you require, you can expect a fully integrated program from study design to data reporting.
Your dedicated early phase project manager will provide you with customized service and 3rd party management/oversight. We deliver full-service programs on time, within budget and to the highest quality to meet your rigorous requirements and those of the regulatory agencies. For more information about Quotient Project Management, click here.
clinical unit with a dedicated 14C ADME ward & Lab
On-site pharmaceutical laboratories and GMP manufacturing
9,000 active healthy volunteers in our database
Over 650 Phase I clinical studies completed
144-bed clinical unit with dedicated FIH wards
On-site pharmacy, with clean rooms for aseptic products
19,000 active healthy volunteers in our database
Recruitment for special subject populations